Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

ConditionsAtrial Fibrillation Atrial Tachycardia Atrial Flutter Congenital Heart Disease Pulmonary Vein Isolation Pulsed Field Ablation Catheter Ablation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorBoston Children's Hospital

About this trial

This is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ablation.

Eligibility criteria

Qualifiers

Adult patients (>= 18 years of age) with repaired or unrepaired congenital heart disease and a history of sustained (>30 seconds) AT

Disqualifiers

History of sustained AF and/or previous catheter or surgical pulmonary vein isolation.

Trial design

Treatments tested in this trial

Pulsed field ablation using a pentaspline ablation catheter

Treatment groups

30 Participants

are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Boston Children's Hospital

Lead sponsor

Brigham and Women's Hospital

Collaborator

Source ClinicalTrials.gov